Cargando…

5-Amino-1-β-D-Ribofuranosyl-Imidazole-4-Carboxamide (AICAR) Reduces Peripheral Inflammation by Macrophage Phenotype Shift

The stimulation of the AMP-activated kinase (AMPK) by 5-amino-1-β-D-ribofuranosyl-imidazole-4-carboxamide (AICAR) has been associated with antihyperalgesia and the inhibition of nociceptive signaling in the spinal cord in models of paw inflammation. The attenuated nociception comes along with a stro...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin, Lisa Maria, Möller, Moritz, Weiss, Ulrike, Russe, Otto Quintus, Scholich, Klaus, Pierre, Sandra, Geisslinger, Gerd, Niederberger, Ellen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651813/
https://www.ncbi.nlm.nih.gov/pubmed/31269729
http://dx.doi.org/10.3390/ijms20133255
_version_ 1783438431439814656
author Martin, Lisa Maria
Möller, Moritz
Weiss, Ulrike
Russe, Otto Quintus
Scholich, Klaus
Pierre, Sandra
Geisslinger, Gerd
Niederberger, Ellen
author_facet Martin, Lisa Maria
Möller, Moritz
Weiss, Ulrike
Russe, Otto Quintus
Scholich, Klaus
Pierre, Sandra
Geisslinger, Gerd
Niederberger, Ellen
author_sort Martin, Lisa Maria
collection PubMed
description The stimulation of the AMP-activated kinase (AMPK) by 5-amino-1-β-D-ribofuranosyl-imidazole-4-carboxamide (AICAR) has been associated with antihyperalgesia and the inhibition of nociceptive signaling in the spinal cord in models of paw inflammation. The attenuated nociception comes along with a strongly reduced paw edema, indicating that peripheral antiinflammatory mechanisms contribute to antinociception. In this study, we investigated the impact of AICAR on the immune cell composition in inflamed paws, as well as the regulation of inflammatory and resolving markers in macrophages. By using fluorescence-activated cell sorting (FACS) analysis and immunofluorescence, we found a significantly increased fraction of proresolving M2 macrophages and anti-inflammatory interleukin (IL)-10 in inflamed tissue, while M1 macrophages and proinflammatory cytokines such as IL-1 were decreased by AICAR in wild type mice. In AMPKα2 knock-out mice, the M2 polarization of macrophages in the paw was missing. The results were supported by experiments in primary macrophage cultures which also showed a shift to a proresolving phenotype with decreased levels of proinflammatory mediators and increased levels of antiinflammatory mediators. However, in the cell cultures, we did not observe differences between the AMPKα2+/+ and −/− cells, thus indicating that the AICAR-induced effects are at least partially AMPK-independent. In summary, our results indicate that AICAR has potent antiinflammatory and proresolving properties in inflammation which are contributing to a reduction of inflammatory edema and antinociception.
format Online
Article
Text
id pubmed-6651813
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-66518132019-08-08 5-Amino-1-β-D-Ribofuranosyl-Imidazole-4-Carboxamide (AICAR) Reduces Peripheral Inflammation by Macrophage Phenotype Shift Martin, Lisa Maria Möller, Moritz Weiss, Ulrike Russe, Otto Quintus Scholich, Klaus Pierre, Sandra Geisslinger, Gerd Niederberger, Ellen Int J Mol Sci Article The stimulation of the AMP-activated kinase (AMPK) by 5-amino-1-β-D-ribofuranosyl-imidazole-4-carboxamide (AICAR) has been associated with antihyperalgesia and the inhibition of nociceptive signaling in the spinal cord in models of paw inflammation. The attenuated nociception comes along with a strongly reduced paw edema, indicating that peripheral antiinflammatory mechanisms contribute to antinociception. In this study, we investigated the impact of AICAR on the immune cell composition in inflamed paws, as well as the regulation of inflammatory and resolving markers in macrophages. By using fluorescence-activated cell sorting (FACS) analysis and immunofluorescence, we found a significantly increased fraction of proresolving M2 macrophages and anti-inflammatory interleukin (IL)-10 in inflamed tissue, while M1 macrophages and proinflammatory cytokines such as IL-1 were decreased by AICAR in wild type mice. In AMPKα2 knock-out mice, the M2 polarization of macrophages in the paw was missing. The results were supported by experiments in primary macrophage cultures which also showed a shift to a proresolving phenotype with decreased levels of proinflammatory mediators and increased levels of antiinflammatory mediators. However, in the cell cultures, we did not observe differences between the AMPKα2+/+ and −/− cells, thus indicating that the AICAR-induced effects are at least partially AMPK-independent. In summary, our results indicate that AICAR has potent antiinflammatory and proresolving properties in inflammation which are contributing to a reduction of inflammatory edema and antinociception. MDPI 2019-07-02 /pmc/articles/PMC6651813/ /pubmed/31269729 http://dx.doi.org/10.3390/ijms20133255 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Martin, Lisa Maria
Möller, Moritz
Weiss, Ulrike
Russe, Otto Quintus
Scholich, Klaus
Pierre, Sandra
Geisslinger, Gerd
Niederberger, Ellen
5-Amino-1-β-D-Ribofuranosyl-Imidazole-4-Carboxamide (AICAR) Reduces Peripheral Inflammation by Macrophage Phenotype Shift
title 5-Amino-1-β-D-Ribofuranosyl-Imidazole-4-Carboxamide (AICAR) Reduces Peripheral Inflammation by Macrophage Phenotype Shift
title_full 5-Amino-1-β-D-Ribofuranosyl-Imidazole-4-Carboxamide (AICAR) Reduces Peripheral Inflammation by Macrophage Phenotype Shift
title_fullStr 5-Amino-1-β-D-Ribofuranosyl-Imidazole-4-Carboxamide (AICAR) Reduces Peripheral Inflammation by Macrophage Phenotype Shift
title_full_unstemmed 5-Amino-1-β-D-Ribofuranosyl-Imidazole-4-Carboxamide (AICAR) Reduces Peripheral Inflammation by Macrophage Phenotype Shift
title_short 5-Amino-1-β-D-Ribofuranosyl-Imidazole-4-Carboxamide (AICAR) Reduces Peripheral Inflammation by Macrophage Phenotype Shift
title_sort 5-amino-1-β-d-ribofuranosyl-imidazole-4-carboxamide (aicar) reduces peripheral inflammation by macrophage phenotype shift
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651813/
https://www.ncbi.nlm.nih.gov/pubmed/31269729
http://dx.doi.org/10.3390/ijms20133255
work_keys_str_mv AT martinlisamaria 5amino1bdribofuranosylimidazole4carboxamideaicarreducesperipheralinflammationbymacrophagephenotypeshift
AT mollermoritz 5amino1bdribofuranosylimidazole4carboxamideaicarreducesperipheralinflammationbymacrophagephenotypeshift
AT weissulrike 5amino1bdribofuranosylimidazole4carboxamideaicarreducesperipheralinflammationbymacrophagephenotypeshift
AT russeottoquintus 5amino1bdribofuranosylimidazole4carboxamideaicarreducesperipheralinflammationbymacrophagephenotypeshift
AT scholichklaus 5amino1bdribofuranosylimidazole4carboxamideaicarreducesperipheralinflammationbymacrophagephenotypeshift
AT pierresandra 5amino1bdribofuranosylimidazole4carboxamideaicarreducesperipheralinflammationbymacrophagephenotypeshift
AT geisslingergerd 5amino1bdribofuranosylimidazole4carboxamideaicarreducesperipheralinflammationbymacrophagephenotypeshift
AT niederbergerellen 5amino1bdribofuranosylimidazole4carboxamideaicarreducesperipheralinflammationbymacrophagephenotypeshift